Visceral pain: The ins and outs, the ups and downs

Current Opinion in Supportive and Palliative Care

Volumn 6, Issue 1, 2012, Pages 17-26

  Sikandar, Shafaq ^a   Dickenson, Anthony H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Descending modulation; Visceral hyperalgesia; Visceral pain; Viscerosomatic convergence

Indexed keywords

CENTRAL NERVOUS SYSTEM; HUMAN; HYPERALGESIA; NOCICEPTION; NOCICEPTIVE PAIN; PAIN ASSESSMENT; PATHOLOGY; PERIPHERAL NEUROPATHY; REVIEW; SENSORY NERVE; VISCERAL PAIN;

CENTRAL NERVOUS SYSTEM; HUMANS; HYPERALGESIA; NOCICEPTION; NOCICEPTIVE PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; VISCERAL AFFERENTS; VISCERAL PAIN;

EID: 84861806373     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e32834f6ec9     Document Type: Review

References (115)

1. Cervero F, Laird JM. Visceral pain. Lancet 1999; 353:2145-2148.
2. Camilleri M, Williams DE. Economic burden of irritable bowel syndrome. Proposed strategies to control expenditures. Pharmacoeconomics 2000; 17:331-338.
3. Farmer AD, Aziz Q. Visceral pain hypersensitivity in functional gastrointestinal disorders. Br Med Bull 2009; 91:123-136.
4. Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 2006; 24:21-37.
5. Quigley EM, Bytzer P, Jones R, Mearin F. Irritable bowel syndrome: the burden and unmet needs in Europe. Dig Liver Dis 2006; 38:717-723.
6. Wang L, Wang X, Wang W, et al. Stress and dysmenorrhoea: a population based prospective study. Occup Environ Med 2004; 61:1021-1026.
7. Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol 1996; 87:55-58.
8. Ohde S, Tokuda Y, Takahashi O, et al. Dysmenorrhea among Japanese women. Int J Gynaecol Obstet 2008; 100:13-17.
9. Patel V, Tanksale V, Sahasrabhojanee M, et al. The burden and determinants of dysmenorrhoea: a population-based survey of 2262 women in Goa, India. BJOG 2006; 113:453-463.
10. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003; 17:643-650.
11. Giamberardino MA, Affaitati G, Costantini R. Referred pain from internal organs. In: Cervero F, Jensen TS, editors. Handbook of Clinical Neurology. Amsterdam: Elsevier; 2006. pp. 343-360.
12. Wroblewski M, Mikulowski P. Peritonitis in geriatric inpatients. Age Ageing 1991; 20:90-94.
13. Olden KW. The challenge of diagnosing irritable bowel syndrome. Rev Gastroenterol Disord 2003; 3 (Suppl. 3):S3-S11.
14. Wilson S, Roberts L, Roalfe A, et al. Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract 2004; 54:495-502.
15. Procacci P, Zoppi M, Maresca M. Visceral sensation. In: Cervero F, Morrison JFB, editors. Progress in pain research. Amsterdam: Elsevier; 1986. pp. 21-28, 39.
16. Hardy JD, Wolff HG, Goodell H. Experimental evidence on the nature of cutaneous hyperalgesia. J Clin Invest 1950; 29:115-140.
17. Ness TJ. Historical and clinical perspectives. In: Gebhart GF, editor. Visceral pain, progress in pain research and management. Seattle: IASP Press; 1995. pp. 3-23.
18. McSwiney BA. Visceral functions of the nervous system. Annu Rev Physiol 1944; 6:365-390.
19. Cervero F. Sensory innervation of the viscera: peripheral basis of visceral pain. Physiol Rev 1994; 74:95-138.
20. Sengupta JN, Gebhart GF. Mechanosensitive afferent fibres in the gastrointestinal and lower urinary tracts. In: Gebhart GF, editor. Visceral pain. Seattle: IASP Press; 1995. pp. 75-98.
21. Gebhart GF. Visceral pain-peripheral sensitisation. Gut 2000; 47 (Suppl 4): iv54-iv55; discussion iv8.
22. Altschuler SM, Bao XM, Bieger D, et al. Viscerotopic representation of the upper alimentary tract in the rat: sensory ganglia and nuclei of the solitary and spinal trigeminal tracts. J Comp Neurol 1989; 283:248-268.
23. Sengupta JN, Gebhart GF. Gastrointestinal afferent fibers and sensation. In: Johnson, LR, editor. Physiology of the gastrointestinal tract. 3rd ed. New York: Raven Press; 1994. pp. 483-519.
24. Langley JN. The autonomic nervous system. Brain 1903; 26:1-16.
25. Cervero F. Visceral nociception: peripheral and central aspects of visceral nociceptive systems. Philos Trans R Soc Lond B Biol Sci 1985; 308:325-337.
26. Janig W. Neurobiology of visceral afferent neurons: neuroanatomy, functions, organ regulations and sensations. Biol Psychol 1996; 42:29-51.
27. Sengupta JN, Gebhart GF. Characterization of mechanosensitive pelvic nerve afferent fibers innervating the colon of the rat. J Neurophysiol 1994; 71:2046-2060.
28. Al-Chaer ED, Traub RJ. Biological basis of visceral pain: recent developments. Pain 2002; 96:221-225.
29. McMahon SB, Koltzenburg M. Silent afferents and visceral pain. In: Fields HL, Liebeskind JC, editors. Pharmacological approaches to the treatment of chronic pain: new concepts and critical issues. Seattle: IASP Press; 1994. pp. 11-30.
30. Feng B, Gebhart GF. Characterization of silent afferents in the pelvic and splanchnic innervations of the mouse colorectum. Am J Physiol Gastrointest Liver Physiol 2011; 300:G170-G180.
31. Schmidt R, Schmelz M, Forster C, et al. Novel classes of responsive and unresponsive C nociceptors in human skin. J Neurosci 1995; 15 (1 Pt 1): 333-341.
32. Weidner C, Schmelz M, Schmidt R, et al. Functional attributes discriminating mechano-insensitive and mechano-responsive C nociceptors in human skin. J Neurosci 1999; 19:10184-10190.
33. Cervero F. Somatic and visceral inputs to the thoracic spinal cord of the cat: effects of noxious stimulation of the biliary system. J Physiol 1983; 337:51-67.
34. Mertz H, Naliboff B, Munakata J, et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109:40-52.
35. Cameron DM, Brennan TJ, Gebhart GF. Hind paw incision in the rat produces long-lasting colon hypersensitivity. J Pain 2008; 9:246-253.
36. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993; 52:259-285.
37. Ness TJ, Gebhart GF. Interactions between visceral and cutaneous nociception in the rat. I. Noxious cutaneous stimuli inhibit visceral nociceptive neurons and reflexes. J Neurophysiol 1991; 66:20-28.
38. Ness TJ, Gebhart GF. Interactions between visceral and cutaneous nociception in the rat. II. Noxious visceral stimuli inhibit cutaneous nociceptive neurons and reflexes. J Neurophysiol 1991; 66:29-39.
39. Mayer EA. Emerging disease model for functional gastrointestinal disorders. Am J Med 1999; 107 (5A):12S-19S.
40. Hunt SP, Mantyh PW. The molecular dynamics of pain control. Nat Rev Neurosci 2001; 2:83-91.
41. Al-Chaer ED, Feng Y, Willis WD. A role for the dorsal column in nociceptive visceral input into the thalamus of primates. J Neurophysiol 1998; 79:3143-3150.
42. Palecek J, Paleckova V, Willis WD. The roles of pathways in the spinal cord lateral and dorsal funiculi in signaling nociceptive somatic and visceral stimuli in rats. Pain 2002; 96:297-307.
43. Palecek J, Willis WD. The dorsal column pathway facilitates visceromotor responses to colorectal distention after colon inflammation in rats. Pain 2003; 104:501-507.
44. Todd AJ. Anatomy of primary afferents and projection neurones in the rat spinal dorsal horn with particular emphasis on substance P and the neurokinin 1 receptor. Exp Physiol 2002; 87:245-249.
45. Bester H, Menendez L, Besson JM, Bernard JF. Spino (trigemino) parabrachiohypothalamic pathway: electrophysiological evidence for an involvement in pain processes. J Neurophysiol 1995; 73:568-585.
46. Blomqvist A,Ma W, Berkley KJ. Spinal input to the parabrachial nucleus in the cat. Brain Res 1989; 480:29-36.
47. Bester H, Matsumoto N, Besson JM, Bernard JF. Further evidence for the involvement of the spinoparabrachial pathway in nociceptive processes: a c-Fos study in the rat. J Comp Neurol 1997; 383:439-458.
48. Craig AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 2002; 3:655-666.
49. Bushnell MC, Duncan GH. Sensory and affective aspects of pain perception: is medial thalamus restricted to emotional issues? Exp Brain Res 1989; 78:415-418.
50. Groenewegen HJ. Organization of the afferent connections of the mediodorsal thalamic nucleus in the rat, related to the mediodorsal-prefrontal topography. Neuroscience 1988; 24:379-431.
51. Cao Z, Wu X, Chen S, et al. Anterior cingulate cortex modulates visceral pain as measured by visceromotor responses in viscerally hypersensitive rats. Gastroenterology 2008; 134:535-543.
52. Moisset X, Bouhassira D, Denis D, et al. Anatomical connections between brain areas activated during rectal distension in healthy volunteers: a visceral pain network. Eur J Pain 2009; 14:142-148.
53. Mertz H, Morgan V, Tanner G, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 2000; 118:842-848.
54. Zhuo M, Sengupta JN, Gebhart GF. Biphasic modulation of spinal visceral nociceptive transmission from the rostroventral medial medulla in the rat. J Neurophysiol 2002; 87:2225-2236.
55. Vera-Portocarrero LP, Xie JY, Kowal J, et al. Descending facilitation from the rostral ventromedial medulla maintains visceral pain in rats with experimental pancreatitis. Gastroenterology 2006; 130:2155-2164.
56. Wilder-Smith CH. The balancing act: endogenous modulation of pain in functional gastrointestinal disorders. Gut 2011; 60:1589-1599.
57. Sikandar S, Dickenson AH. Pregabalin modulation of spinal and brainstem visceral nociceptive processing. Pain 2011; 152:2312-2322.
58. Chandler MJ, Oh UT, Hobbs SF, Foreman RD. Responses of feline raphespinal neurons to urinary bladder distension. J Auton Nerv Syst 1994; 47:213-224.
59. Brink TS, Mason P. Raphe magnus neurons respond to noxious colorectal distension. J Neurophysiol 2003; 89:2506-2515.
60. Zhuo M, Gebhart GF. Facilitation and attenuation of a visceral nociceptive reflex from the rostroventral medulla in the rat. Gastroenterology 2002; 122:1007-1019.
61. Kern MK, Shaker R. Cerebral cortical registration of subliminal visceral stimulation. Gastroenterology 2002; 122:290-298.
62. Miron D, Duncan GH, Bushnell MC. Effects of attention on the intensity and unpleasantness of thermal pain. Pain 1989; 39:345-352.
63. Bantick SJ, Wise RG, Ploghaus A, et al. Imaging how attention modulates pain in humans using functional MRI. Brain 2002; 125 (Pt 2):310-319.
64. Dunckley P, Wise RG, Fairhurst M, et al. A comparison of visceral and somatic pain processing in the human brainstem using functional magnetic resonance imaging. J Neurosci 2005; 25:7333-7341.
65. Woolf CJ, Ma Q. Nociceptors: noxious stimulus detectors. Neuron 2007; 55:353-364.
66. Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat Rev Neurosci 2005; 6:521-532.
67. Akopian AN, Sivilotti L, Wood JN. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 1996; 379:257-262.
68. Laird JMA, Fernand C. Voltage-gated sodium channels and visceral pain In: Parnham MJ, Coward K, Baker MD, editors. Sodium channels, pain, and analgesia. Basel: Birkhäuser Basel; 2005. pp. 63-70.
69. Gold MS, Zhang L, Wrigley DL, Traub RJ. Prostaglandin E(2) modulates TTX-R I(Na) in rat colonic sensory neurons. J Neurophysiol 2002; 88:1512-1522.
70. Hillsley K, Lin JH, Stanisz A, et al. Dissecting the role of sodium currents in visceral sensory neurons in a model of chronic hyperexcitability using Nav1.8 and Nav1.9 null mice. J Physiol 2006; 576 (Pt 1):257-267.
71. Laird JM, Souslova V, Wood JN, Cervero F. Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS/PN3)-null mice. J Neurosci 2002; 22:8352-8356.
72. Matthews EA, Wood JN, Dickenson AH. Na(v) 1.8-null mice show stimulusdependent deficits in spinal neuronal activity. Mol Pain 2006; 2:5.
73. Leo S, D'Hooge R, Meert T. Exploring the role of nociceptor-specific sodium channels in pain transmission using Nav1.8 and Nav1.9 knockout mice. Behav. Brain Res 2010; 208:149-157.
74. Hwang SW, Oh U. Hot channels in airways: pharmacology of the vanilloid receptor. Curr Opin Pharmacol 2002; 2:235-242.
75. Hwang SJ, Valtschanoff JG. Vanilloid receptor VR1-positive afferents are distributed differently at different levels of the rat lumbar spinal cord. Neurosci Lett 2003; 349:41-44.
76. Bortolotti M, Porta S. Effect of red pepper on symptoms of irritable bowel syndrome: preliminary study. Dig Dis Sci 2011; 56:3288-3295.
77. Brock C, Andresen T, Frokjaer JB, et al. Central pain mechanisms following combined acid and capsaicin perfusion of the human oesophagus. Eur J Pain 2010; 14:273-281.
78. Laird JM, Martinez-Caro L, Garcia-Nicas E, Cervero F. A new model of visceral pain and referred hyperalgesia in the mouse. Pain 2001; 92:335-342.
79. Sanoja R, Tortorici V, Fernandez C, et al. Role of RVM neurons in capsaicinevoked visceral nociception and referred hyperalgesia. Eur J Pain 2010; 14:120 e1-120 e9.
80. Gonlachanvit S, Mahayosnond A, Kullavanijaya P. Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: evidence for capsaicin-sensitive visceral nociception hypersensitivity. Neurogastroenterol Motil 2009; 21:23-32.
81. Ravnefjord A, Brusberg M, Kang D, et al. Involvement of the transient receptor potential vanilloid 1 (TRPV1) in the development of acute visceral hyperalgesia during colorectal distension in rats. Eur J Pharmacol 2009; 611:85-91.
82. Yiangou Y, Facer P, Dyer NH, et al. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 2001; 357:1338-1339.
83. Akbar A, Yiangou Y, Facer P, et al. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 2008; 57:923-929.
84. Harrington AM, Hughes PA, Martin CM, et al. A novel role for TRPM8 in visceral afferent function. Pain 2011; 152:1459-1468.
85. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009; 10:895-926.
86. Suzuki R, Rahman W, Rygh LJ, et al. Spinal-supraspinal serotonergic circuits regulating neuropathic pain and its treatment with gabapentin. Pain 2005; 117:292-303.
87. Stawowy M, Drewes AM, Arendt-Nielsen L, Funch-Jensen P. Somatosensory changes in the referred pain area before and after cholecystectomy in patients with uncomplicated gallstone disease. Scand J Gastroenterol 2006; 41:833-837.
88. Drewes AM, Pedersen J, Reddy H, et al. Central sensitization in patients with noncardiac chest pain: a clinical experimental study. Scand J Gastroenterol 2006; 41:640-649.
89. Verne GN, Robinson ME, Vase L, Price DD. Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain 2003; 105:223-230.
90. Willert RP, Delaney C, Kelly K, et al. Exploring the neurophysiological basis of chest wall allodynia induced by experimental oesophageal acidification -evidence of central sensitization. Neurogastroenterol Motil 2007; 19:270-278.
91. Mayer EA, Munakata J, Mertz H, et al. Visceral hyperalgesia and irritable bowel syndrome. In: Gebhart GF, editor. Visceral pain. Seattle: IASP Press; 1995. pp. 429-468.
92. Ness TJ, Metcalf AM, Gebhart GF. A psychophysiological study in humans using phasic colonic distension as a noxious visceral stimulus. Pain 1990; 43:377-386.
93. Mayer EA. Visceral hyperalgesia and IBS. In: Gebhart GF, editor. Visceral pain, progress in research and management. Seattle: IASP Press; 2005. pp. 429-468.
94. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123:2108-2131.
95. Ness TJ, Lewis-Sides A, Castroman P. Characterization of pressor and visceromotor reflex responses to bladder distention in rats: sources of variability and effect of analgesics. J Urol 2001; 165:968-974.
96. Randich A, Uzzell T, Cannon R, Ness TJ. Inflammation and enhanced nociceptive responses to bladder distension produced by intravesical zymosan in the rat. BMC Urol 2006; 6:2.
97. Barbara G, Stanghellini V. Biomarkers in IBS: when will they replace symptoms for diagnosis and management? Gut 2009; 58:1571-1575.
98. Piche T, Barbara G, Aubert P, et al. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 2009; 58:196-201.
99. Whitehead WE, Crowell MD, Robinson JC, et al. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 1992; 33:825-830.
100. Drossman DA, Leserman J, Nachman G, et al. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med 1990; 113:828-833.
101. Elam M, Thoren P, Svensson TH. Locus coeruleus neurons and sympathetic nerves: activation by visceral afferents. Brain Res 1986; 375:117-125.
102. O'Mahony S, Coelho AM, Fitzgerald P, et al. The effects of gabapentin in two animal models of co-morbid anxiety and visceral hypersensitivity. Eur J Pharmacol 2011; 667 (1-3):169-174.
103. Sharma A, Van Oudenhove L, Paine P, et al. Anxiety increases acidinduced esophageal hyperalgesia. Psychosom Med 2010; 72:802-809.
104. Damasio AR. The feeling of what happens: body and emotion in the making of consciousness. 1st ed. New York: Harcourt Brace; 1999.
105. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet 1999; 354:936-939.
106. Mayer EA, Naliboff BD, Craig AD. Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology 2006; 131:1925-1942.
107. Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA 2000; 283:1710-1714.
108. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain 2008; 24:479-496.
109. Drewes AM, Wilder-Smith CH, Staahl C. Chronic abdominal pain: evaluation, management of common gastrointestinal, urogenital diseases. In: Castro-Lopes J, Raja, SN, Schmelz M, editors. Pain 2008 refresher course syllabus. Seattle: IASP Press; 2008. pp. 381-391.
110. Houghton LA, Fell C, Whorwell PJ, et al. Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome. Gut 2007; 56:1218-1225.
111. Olesen SS, Graversen C, Olesen AE, et al. Randomised clinical trial: pregabalin attenuates experimental visceral pain through sub-cortical mechanisms in patients with painful chronic pancreatitis. Aliment Pharmacol Ther 2011; 34:878-887.
112. Ohashi-Doi K, Gale JD, Kurebayashi Y. Pregabalin inhibits accelerated defecation and decreased colonic nociceptive threshold in sensitized rats. Eur J Pharmacol 2010; 643:107-112.
113. Bannister K, Sikandar S, Bauer CS, et al. Pregabalin suppresses spinal neuronal hyperexcitability and visceral hypersensitivity in the absence of peripheral pathophysiology. Anesthesiology 2011; 115:144-152.
114. Knowles CH. New horizons in the pathogenesis of gastrointestinal neuromuscular disease. J Pediatr Gastroenterol Nutr 2007; 45 (Suppl 2):S97-S102.
115. Knowles CH, Aziz Q. Basic and clinical aspects of gastrointestinal pain. Pain 2009; 141:191-209.